Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
First Claim
1. A cytotoxic drug conjugate of formula:
-
space="preserve" listing-type="equation">Z.sup.3 (CO--Alk.sup.1 --Sp.sup.1 --Ar--Sp.sup.2 --Alk.sup.2 --C(Z.sup.1)═
Z.sup.2)mwhereinZ3 is a protein selected from mono- and polyclonal antibodies, their antigen-recognizing fragments, and their chemically or genetically manipulated counterparts, and growth factors and their chemically or genetically manipulated counterparts, wherein a covalent bond to the protein is an amide formed from reaction with lysine side chains, or a steroid, wherein the covalent bond to the steroid is an amide or an ester;
Alk and Alk2 are independently a bond or branched or unbranched (C1 -C10) alkylene chain;
Sp1 is a bond, --S--, --O--, --CONH--, --NHCO--, --NR'"'"'--, --N(CH2 CH2)2 N--, or --X--Ar'"'"'--Y--(CH2)n --Z wherein X, Y, and Z are independently a bond, --NR'"'"'--, --S--, or --O--, with the proviso that when n=0, then at least one of Y and Z must be a bond and Ar'"'"' is 1,2-, 1,3-, or 1 ,4-phenylene optionally substituted with one, two, or three groups of (C1 -C5) alkyl, (C1 -C4) alkoxy, (C1 -C4) thioalkoxy, halogen, nitro, COOR'"'"', CONHR'"'"', O(CH2)n COOR'"'"', S(CH2)n COOR'"'"', O(CH2)n CONHR'"'"', or S(CH2)n CONHR'"'"', with the proviso that when Alk1 is a bond, Sp1 is a bond;
n is an integer from 0 to 5;
R'"'"' is a branched or unbranched (C1 -C5) chain optionally substituted by one or two groups of --OH, (C1 -C4) alkoxy, (C1 -C4) thioalkoxy, halogen, nitro, (C1 -C3) dialkylamino, or (C1 -C3) trialkylammonium --A- where A- is a pharmaceutically acceptable anion completing a salt;
Ar is 1,2-, 1,3-, or 1,4-phenylene optionally substituted with one, two, or three groups of (C1 -C6) alkyl, (C1 -C5) alkoxy, (C1 -C4) thioalkoxy, halogen, nitro, or COOR'"'"', CONHR'"'"', O(CH2)n COOR'"'"', S(CH2)n COOR'"'"', O(CH2)n CONHR'"'"', or S(CH2)n CONHR'"'"' wherein n and R'"'"' are as defined above or a 1,2-, 1,3-, 1,4-, 1,5-, 1,6-, 1,7-, 1,8-, 2,3-, 2,6-, or 2,7-naphthylidene or ##STR15## each naphthylidene or phenothiazine optionally substituted with one, two, three, or four groups of (C1 -C6) alkyl, (C1 -C5) alkoxy, (C1 -C4) thioalkoxy, halogen, nitro, or COOR'"'"', CONHR'"'"', O(CH2)n COOR'"'"', S(CH2)n COOR'"'"', O(CH2)n CONHR'"'"', or S(CH2)n CONHR'"'"' wherein n and R'"'"' are as defined above, with the proviso that when Ar is naphthylidene, Z1 is not hydrogen and with the proviso that when Ar is phenothiazine, Sp1 is a bond only connected to nitrogen;
Sp2 is a bond, --S--, or --O--, with the proviso that when Alk2 is a bond, Sp2 is a bond;
Z1 is H, (C1 -C5) alkyl, or phenyl optionally substituted with one, two, or three groups of (C1 -C5) alkyl, (C1 -C4) alkoxy, (C1 -C4) thioalkoxy, halogen, nitro, COOR'"'"', CONHR'"'"', O(CH2)n COOR'"'"', S(CH2)n COOR'"'"', O(CH2)n CONHR'"'"', or S(CH2),CONHR'"'"' wherein n and R'"'"' are as defined above;
Z2 is Q--Sp--S--S--W, wherein W is ##STR16## R5 is --CH3, --C2 H5, or --CH(CH3)2 ;
X is an iodine or bromine atom;
R5'"'"' is a hydrogen or the group RCO, wherein R is hydrogen, branched or unbranched (C1 -C10) alkyl or (C1 -C10) alkylene group, a (C6 -C1 l) aryl group, a (C6 -C11) aryl-alkyl (C1 -C5) group, or a heteroaryl or heteroaryl- alkyl (C1 -C5) group wherein heteroaryl is 2- or 3-furyl, 2- or 3-thienyl, 2- or 3-(N-methylpyrrolyl), 2-, 3-, or 4-pyridyl, 2-, 4-, or 5-(N-methylimidizolyl), 2-, 4-, or 5-oxazolyl, 2-, 3-, 5-, or 6-pyrimidinyl, 2-, 3-, 4-, 5-, 6-, 7-, or 8-quinolyl, or 1-, 3-, 4-, 5-, 6-, 7-, or 8-heteroaryl optionally substituted by one or more hydroxy, amino, carboxy, halo, nitro, lower (C1 -C3) alkoxy, or lower (C1 -C5) thioalkoxy groups;
Sp is a straight or branched-chain divalent or trivalent (C1 -C18) radical, divalent or trivalent aryl or heteroaryl radical, divalent or trivalent (C3 -C18) cycloalkyl or heterocycloalkyl radical, divalent or trivalent aryl- or heteroaryl-alkyl (C1 -C18) radical, divalent or trivalent cycloalkyl- or heterocycloalkyl-alkyl (C1 -C18) radical or divalent or trivalent (C2 -C18) unsaturated alkyl radical, wherein heteroaryl is furyl, thienyl, N-methylpyrrolyl, pyridinyl, N-methylimidazolyl, oxazolyl, pyrimidinyl, quinolyl, isoquinolyl, N-methylcarbazoyl, aminocoumarinyl, or phenazinyl and wherein when Sp is a trivalent radical, Sp can be additionally substituted by lower (C1 -C5) dialkylamino, lower (C1 -C5) alkoxy, hydroxy, or lower (C1 -C5) alkylthio groups; and
Q is ═
NHNCO--, ═
NHNCS--, ═
NHNCONH--, ═
NHNCSNH--, or ═
NHO--m is from about 0.1 to 15.
3 Assignments
0 Petitions
Accused Products
Abstract
This invention describes carrier-drug conjugates prepared from disulfide analogs of the calicheamicin family of potent antitumor antibiotics and their derivatives, as well as similar analogs from related antitumor antibiotics such as the esperamicins. The carrier can be an antibody, growth factor, or steroid which targets an undesired population of cells, such as those of a tumor. Whole protein carriers as well as their antigen-recognizing fragments and their chemically or genetically manipulated counterparts are useful for the targeting portion of the conjugates. This invention includes compounds required for the synthesis of these conjugates, appropriate pharmaceutical compositions of the carrier-drug conjugates, and their method of use.
424 Citations
29 Claims
-
1. A cytotoxic drug conjugate of formula:
-
space="preserve" listing-type="equation">Z.sup.3 (CO--Alk.sup.1 --Sp.sup.1 --Ar--Sp.sup.2 --Alk.sup.2 --C(Z.sup.1)═
Z.sup.2)mwherein Z3 is a protein selected from mono- and polyclonal antibodies, their antigen-recognizing fragments, and their chemically or genetically manipulated counterparts, and growth factors and their chemically or genetically manipulated counterparts, wherein a covalent bond to the protein is an amide formed from reaction with lysine side chains, or a steroid, wherein the covalent bond to the steroid is an amide or an ester; Alk and Alk2 are independently a bond or branched or unbranched (C1 -C10) alkylene chain; Sp1 is a bond, --S--, --O--, --CONH--, --NHCO--, --NR'"'"'--, --N(CH2 CH2)2 N--, or --X--Ar'"'"'--Y--(CH2)n --Z wherein X, Y, and Z are independently a bond, --NR'"'"'--, --S--, or --O--, with the proviso that when n=0, then at least one of Y and Z must be a bond and Ar'"'"' is 1,2-, 1,3-, or 1 ,4-phenylene optionally substituted with one, two, or three groups of (C1 -C5) alkyl, (C1 -C4) alkoxy, (C1 -C4) thioalkoxy, halogen, nitro, COOR'"'"', CONHR'"'"', O(CH2)n COOR'"'"', S(CH2)n COOR'"'"', O(CH2)n CONHR'"'"', or S(CH2)n CONHR'"'"', with the proviso that when Alk1 is a bond, Sp1 is a bond; n is an integer from 0 to 5; R'"'"' is a branched or unbranched (C1 -C5) chain optionally substituted by one or two groups of --OH, (C1 -C4) alkoxy, (C1 -C4) thioalkoxy, halogen, nitro, (C1 -C3) dialkylamino, or (C1 -C3) trialkylammonium --A- where A- is a pharmaceutically acceptable anion completing a salt; Ar is 1,2-, 1,3-, or 1,4-phenylene optionally substituted with one, two, or three groups of (C1 -C6) alkyl, (C1 -C5) alkoxy, (C1 -C4) thioalkoxy, halogen, nitro, or COOR'"'"', CONHR'"'"', O(CH2)n COOR'"'"', S(CH2)n COOR'"'"', O(CH2)n CONHR'"'"', or S(CH2)n CONHR'"'"' wherein n and R'"'"' are as defined above or a 1,2-, 1,3-, 1,4-, 1,5-, 1,6-, 1,7-, 1,8-, 2,3-, 2,6-, or 2,7-naphthylidene or ##STR15## each naphthylidene or phenothiazine optionally substituted with one, two, three, or four groups of (C1 -C6) alkyl, (C1 -C5) alkoxy, (C1 -C4) thioalkoxy, halogen, nitro, or COOR'"'"', CONHR'"'"', O(CH2)n COOR'"'"', S(CH2)n COOR'"'"', O(CH2)n CONHR'"'"', or S(CH2)n CONHR'"'"' wherein n and R'"'"' are as defined above, with the proviso that when Ar is naphthylidene, Z1 is not hydrogen and with the proviso that when Ar is phenothiazine, Sp1 is a bond only connected to nitrogen; Sp2 is a bond, --S--, or --O--, with the proviso that when Alk2 is a bond, Sp2 is a bond; Z1 is H, (C1 -C5) alkyl, or phenyl optionally substituted with one, two, or three groups of (C1 -C5) alkyl, (C1 -C4) alkoxy, (C1 -C4) thioalkoxy, halogen, nitro, COOR'"'"', CONHR'"'"', O(CH2)n COOR'"'"', S(CH2)n COOR'"'"', O(CH2)n CONHR'"'"', or S(CH2),CONHR'"'"' wherein n and R'"'"' are as defined above; Z2 is Q--Sp--S--S--W, wherein W is ##STR16## R5 is --CH3, --C2 H5, or --CH(CH3)2 ;
X is an iodine or bromine atom;
R5'"'"' is a hydrogen or the group RCO, wherein R is hydrogen, branched or unbranched (C1 -C10) alkyl or (C1 -C10) alkylene group, a (C6 -C1 l) aryl group, a (C6 -C11) aryl-alkyl (C1 -C5) group, or a heteroaryl or heteroaryl- alkyl (C1 -C5) group wherein heteroaryl is 2- or 3-furyl, 2- or 3-thienyl, 2- or 3-(N-methylpyrrolyl), 2-, 3-, or 4-pyridyl, 2-, 4-, or 5-(N-methylimidizolyl), 2-, 4-, or 5-oxazolyl, 2-, 3-, 5-, or 6-pyrimidinyl, 2-, 3-, 4-, 5-, 6-, 7-, or 8-quinolyl, or 1-, 3-, 4-, 5-, 6-, 7-, or 8-heteroaryl optionally substituted by one or more hydroxy, amino, carboxy, halo, nitro, lower (C1 -C3) alkoxy, or lower (C1 -C5) thioalkoxy groups;Sp is a straight or branched-chain divalent or trivalent (C1 -C18) radical, divalent or trivalent aryl or heteroaryl radical, divalent or trivalent (C3 -C18) cycloalkyl or heterocycloalkyl radical, divalent or trivalent aryl- or heteroaryl-alkyl (C1 -C18) radical, divalent or trivalent cycloalkyl- or heterocycloalkyl-alkyl (C1 -C18) radical or divalent or trivalent (C2 -C18) unsaturated alkyl radical, wherein heteroaryl is furyl, thienyl, N-methylpyrrolyl, pyridinyl, N-methylimidazolyl, oxazolyl, pyrimidinyl, quinolyl, isoquinolyl, N-methylcarbazoyl, aminocoumarinyl, or phenazinyl and wherein when Sp is a trivalent radical, Sp can be additionally substituted by lower (C1 -C5) dialkylamino, lower (C1 -C5) alkoxy, hydroxy, or lower (C1 -C5) alkylthio groups; and Q is ═
NHNCO--, ═
NHNCS--, ═
NHNCONH--, ═
NHNCSNH--, or ═
NHO--m is from about 0.1 to 15. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)
-
Specification